» Articles » PMID: 7563329

Changing Age Incidence and Pathological Types of Schistosoma-associated Bladder Carcinoma

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1995 Nov 1
PMID 7563329
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The changes in certain characteristic features of schistosoma-associated bladder carcinoma are determined.

Materials And Methods: A retrospective study was done of patients with schistosoma-associated bladder carcinoma treated between 1962 and 1967, and between 1987 and 1992.

Results: Mean patient age increased from 47 +/- 13.6 to 53 +/- 12.2 years and the male-to-female ratio changed from 7.8:1 to 4.9:1. Tumors showed a decreased incidence of nodular (58.7% versus 83.4%) and squamous (54% versus 65.8%) cell types, and an increased incidence of papillary (34.8% versus 4.3%) and transitional (42% versus 31%) cell types. All changes were statistically significant (p < 0.05) and paralleled by an increased incidence of low degree schistosomal infestation from 18.6 to 47.8% (p < 0.05).

Conclusions: The shift in age incidence and pathological findings towards those of nonschistosomal cases could conceivably be attributed to the increased incidence of low infestation in recent years. The change in male-to-female ratio is probably due to more exposure of women to schistosomal infestation than has occurred previously.

Citing Articles

Hematobium schistosomiasis control for health management of labor force generation at Nkhotakota and Lilongwe in the Republic of Malawi-assumed to be related to occupational risk.

Mishima N, Jemu S, Kuroda T, Tabuchi K, Darcy A, Shimono T Trop Med Health. 2019; 47:28.

PMID: 31073271 PMC: 6498665. DOI: 10.1186/s41182-019-0155-8.


Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients.

Rambau P, Chalya P, Jackson K Infect Agent Cancer. 2013; 8(1):19.

PMID: 23705833 PMC: 3665673. DOI: 10.1186/1750-9378-8-19.


Urinary bladder cancer risk factors in Egypt: a multicenter case-control study.

Zheng Y, Amr S, Saleh D, Dash C, Ezzat S, Mikhail N Cancer Epidemiol Biomarkers Prev. 2011; 21(3):537-46.

PMID: 22147365 PMC: 3297723. DOI: 10.1158/1055-9965.EPI-11-0589.


Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer.

Urbanek C, Goodison S, Chang M, Porvasnik S, Sakamoto N, Li C BMC Cancer. 2011; 11:233.

PMID: 21663671 PMC: 3129326. DOI: 10.1186/1471-2407-11-233.


Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer.

El-Chennawi F, Auf F, Metwally S, Mosaad Y, Shaaban A, El-Baz M World J Gastrointest Oncol. 2010; 1(1):62-8.

PMID: 21160776 PMC: 2999101. DOI: 10.4251/wjgo.v1.i1.62.